Recent studies in the field of microbiology have overturned prior beliefs on the mechanism of action of antibiotics. These findings hold promise for the future development of antibiotic drugs for combatting the rise in superbugs worldwide. But first, the mystery surrounding antibiotics must be solved.
Recent research on the worm C. elegans reveals a connection between the gene SKN-1, proline, and fat accumulation. In the future, miracle drugs may target these genes to prevent weight gain, even in the condition of a high-sugar diet.
Amputees have reported that mind-controlled prosthetics allow them to “feel” their hands for the first time since their amputation. These prosthetics use sophisticated algorithms to relay sensory information to the brain, as well as implanted electrodes in the arm to provide refined, natural movement actuated by the mind of the wearer.
How do the mind and body interact? Yale alumnus Dr. David Spiegel (YC ’67) draws upon his experiences in both philosophy and psychology to answer this question.
Lack of transparency can hinder cooperation in clinical research. In conjunction with the Yale Open Data Access Project, Johnson & Johnson hopes to remedy this issue.
Dr. Robert Needlman, a pediatrician and professor in Cleveland, Ohio, took a noteworthy path from being an English major at Yale to practicing, teaching, and writing about pediatrics. He is known for updating the classic parenting book “Dr. Spock’s Baby and Child Care.”
Sterling Professor of Genetics Richard Lifton has been awarded a Breakthrough Prize in Life Sciences for his research on the genes and biochemical mechanisms of hypertension.
Yale School of Medicine research team finds evidence supporting the use of oxytocin as a treatment for autism spectral disorder.
The Strittmatter Lab has uncovered the hidden protein that serves as the intermediary in the downward spiral towards Alzheimer’s disease; this protein is the target for one of the most innovative drug interventions to date.
Bacteria all around us produce an endless variety of bioactive small molecules. Yale Chemistry Professor, Jason Crawford, has harnessed rapid sequencing technology to mine the bacterial genome in search of novel natural products for drug development.